Cargando…

The acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients

OBJECTIVES: Previous studies have shown an association between systemic hypertension and intraocular pressure (IOP). We analyzed the relationship between the decreases of the blood pressure (BP) and IOP in hypertensive patients. METHODS: The study includes a total of 214 patients: 158 hypertensive a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiambeng, Canan, Batur, Ali, Dikmetas, Özlem, Aksu, Nalan Metin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355068/
https://www.ncbi.nlm.nih.gov/pubmed/35936951
http://dx.doi.org/10.4103/2452-2473.348441
_version_ 1784763210468950016
author Tiambeng, Canan
Batur, Ali
Dikmetas, Özlem
Aksu, Nalan Metin
author_facet Tiambeng, Canan
Batur, Ali
Dikmetas, Özlem
Aksu, Nalan Metin
author_sort Tiambeng, Canan
collection PubMed
description OBJECTIVES: Previous studies have shown an association between systemic hypertension and intraocular pressure (IOP). We analyzed the relationship between the decreases of the blood pressure (BP) and IOP in hypertensive patients. METHODS: The study includes a total of 214 patients: 158 hypertensive and 56 normotensive patients as study and control groups, respectively. The IOP of each eye in both the groups was measured once with a noncontact tonometer at presentation and an hour after BP reduction to normal in the study group. We analyzed the reduction in IOP with decreasing BP. RESULTS: In the study group, the mean IOP was 15.29 ± 4.05 mmHg in the right and 15.11 ± 3.78 mmHg in the left eyes. The mean IOP measured an hour after the patients became normotensive was 13.78 ± 4.06 mmHg in the right and 13.51 ± 3.82 in the left eyes. There was a statistically significant decrease in the IOPs (P < 0.001). The mean IOP in the control group was 13.54 ± 3.51 mmHg in the right and 13.20 ± 3.33 mmHg in the left eyes. The mean IOP at presentation in the study and control groups was found to be significantly different (P < 0.001). CONCLUSIONS: Patients in the study group showed a significantly higher IOP compared to patients in the normotensive group. Furthermore, patients in the study group showed a significant reduction in IOP after BP reduction. This may indicate that uncontrolled hypertension poses a risk for prolonged higher IOP. Prolonged higher IOP can be considered a risk factor for the glaucoma.
format Online
Article
Text
id pubmed-9355068
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93550682022-08-06 The acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients Tiambeng, Canan Batur, Ali Dikmetas, Özlem Aksu, Nalan Metin Turk J Emerg Med Original Article OBJECTIVES: Previous studies have shown an association between systemic hypertension and intraocular pressure (IOP). We analyzed the relationship between the decreases of the blood pressure (BP) and IOP in hypertensive patients. METHODS: The study includes a total of 214 patients: 158 hypertensive and 56 normotensive patients as study and control groups, respectively. The IOP of each eye in both the groups was measured once with a noncontact tonometer at presentation and an hour after BP reduction to normal in the study group. We analyzed the reduction in IOP with decreasing BP. RESULTS: In the study group, the mean IOP was 15.29 ± 4.05 mmHg in the right and 15.11 ± 3.78 mmHg in the left eyes. The mean IOP measured an hour after the patients became normotensive was 13.78 ± 4.06 mmHg in the right and 13.51 ± 3.82 in the left eyes. There was a statistically significant decrease in the IOPs (P < 0.001). The mean IOP in the control group was 13.54 ± 3.51 mmHg in the right and 13.20 ± 3.33 mmHg in the left eyes. The mean IOP at presentation in the study and control groups was found to be significantly different (P < 0.001). CONCLUSIONS: Patients in the study group showed a significantly higher IOP compared to patients in the normotensive group. Furthermore, patients in the study group showed a significant reduction in IOP after BP reduction. This may indicate that uncontrolled hypertension poses a risk for prolonged higher IOP. Prolonged higher IOP can be considered a risk factor for the glaucoma. Wolters Kluwer - Medknow 2022-07-01 /pmc/articles/PMC9355068/ /pubmed/35936951 http://dx.doi.org/10.4103/2452-2473.348441 Text en Copyright: © 2022 Turkish Journal of Emergency Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Tiambeng, Canan
Batur, Ali
Dikmetas, Özlem
Aksu, Nalan Metin
The acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients
title The acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients
title_full The acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients
title_fullStr The acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients
title_full_unstemmed The acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients
title_short The acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients
title_sort acute effect of systemic blood pressure reduction on intraocular pressure in hypertensive patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355068/
https://www.ncbi.nlm.nih.gov/pubmed/35936951
http://dx.doi.org/10.4103/2452-2473.348441
work_keys_str_mv AT tiambengcanan theacuteeffectofsystemicbloodpressurereductiononintraocularpressureinhypertensivepatients
AT baturali theacuteeffectofsystemicbloodpressurereductiononintraocularpressureinhypertensivepatients
AT dikmetasozlem theacuteeffectofsystemicbloodpressurereductiononintraocularpressureinhypertensivepatients
AT aksunalanmetin theacuteeffectofsystemicbloodpressurereductiononintraocularpressureinhypertensivepatients
AT tiambengcanan acuteeffectofsystemicbloodpressurereductiononintraocularpressureinhypertensivepatients
AT baturali acuteeffectofsystemicbloodpressurereductiononintraocularpressureinhypertensivepatients
AT dikmetasozlem acuteeffectofsystemicbloodpressurereductiononintraocularpressureinhypertensivepatients
AT aksunalanmetin acuteeffectofsystemicbloodpressurereductiononintraocularpressureinhypertensivepatients